Continuer?

La page que vous recherchez est disponible en anglais.sur notre site global www.capsugel.com

Pour visiter cette page sélectioner continuer.

Continuer
Annuler

DRcaps® Capsules: Liberação Direcionada Comprovada para Ingredientes Sensíveis a Ácidos

As cápsulas DRcaps® ajudam a proteger ingredientes de suplementos alimentares sensíveis ao ácido estomacal. The innovative DRcaps® capsule targets release after an extended time period, protecting ingredients from degradation in the stomach.
DRcaps® Capsules: Liberação Direcionada Comprovada para Ingredientes Sensíveis a Ácidos

DRcaps® Capsules Disintegration Performance in Human Subjects

To clinically assess the efficacy of DRcaps® capsules for resistance to stomach acids for delayed delivery properties of ingredients, Capsugel commissioned an independent laboratory to conduct a gamma scintigraphic study. 
The study was designed to investigate the in vivo behavior of unbanded DRcaps® capsules using qualitative and quantitative scintigraphic methods to assess the GI transit of DRcaps® capsules and the release of capsule contents based on the scintigraphic images obtained.

Each subject consumed a light breakfast approximately 30 minutes prior to dosing a DRcaps® capsule containing 300mg of lactose, 10mg of which was radiolabelled. Anterior and posterior images were taken after dosing and then every 5 minutes up to 4 hours post-dose.

Resultados-chave do Estudo

DRcaps® desintegração in vivo
DRcaps™ desintegração in vivo

Links Relacionados

Cápsulas DRcaps®, uma solução para produtos de cuidados com a Saúde e Nutrição
Cápsulas DRcaps®, a escolha preferida para você e seus clientes
Cápsulas DRcaps®, uma alternativa simples para processos de revestimento

Recursos Adicionais

Folheto com uma visão geral das cápsulas DRcaps®


Powered by Translations.com GlobalLink OneLink SoftwarePowered By OneLink